PLASMA NATRIURETIC PEPTIDES LEVELS AND ECHOCARDIOGRAPHIC FINDINGS IN LATE SUBCLINICAL ANTHRACYCLINE TOXICITY

被引:4
作者
Kantar, Mehmet [1 ]
Levent, Erturk [1 ]
Cetingul, Nazan [1 ]
Ulger, Zulal [1 ]
Ozyurek, Ruhi [1 ]
Aksoylar, Serap [1 ]
Kansoy, Savas [1 ]
机构
[1] Ege Univ, Sch Med, Dept Pediat, Pediat Oncol & Transplantat Unit, Izmir, Turkey
关键词
anthracycline; cardiac toxicity; children; natriuretic peptides; echocardiography;
D O I
10.1080/08880010802435393
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The purpose of this study was to evaluate late cardiac toxicity by comprehensive echocardiographic study, and to determine whether plasma atrial natriuretic peptide and brain natriuretic peptide levels might be indicators of neurohumoral activation. The study included 49 long-term survivors and 21 controls. A wide variety of echocardiographic parameters were measured or calculated. Plasma peptide levels were determined. Patients had significant changes in different echocardiographic parameters that are suggestive of LV systolic and diastolic dysfunction. Plasma peptide levels were not increased. The authors have found significant subclinic cardiotoxicity by echocardiography. Survivors seem to have normal plasma natriuretic peptide levels in long-term period.
引用
收藏
页码:723 / 733
页数:11
相关论文
共 46 条
[11]   Plasma levels of natriuretic peptides in relation to doxorubicin-induced cardiotoxicity and cardiac function in children with cancer [J].
Hayakawa, F ;
Komada, Y ;
Hirayama, M ;
Hori, H ;
Ito, M ;
Sakurai, M .
MEDICAL AND PEDIATRIC ONCOLOGY, 2001, 37 (01) :4-9
[12]   Noninvasive evaluation of late anthracycline cardiac toxicity in childhood cancer survivors [J].
Hudson, Melissa M. ;
Rai, Shesh N. ;
Nunez, Cesar ;
Merchant, Thomas E. ;
Marina, Neyssa M. ;
Zalamea, Nia ;
Cox, Cheryl ;
Phipps, Sean ;
Pompeu, Ronald ;
Rosenthal, David .
JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (24) :3635-3643
[13]   Left ventricular systolic and diastolic function after anthracycline chemotherapy in childhood [J].
Iarussi, D ;
Galderisi, M ;
Ratti, G ;
Tedesco, MA ;
Indolfi, P ;
Casale, F ;
Di Tullio, MT ;
de Divitiis, O ;
Iacono, A .
CLINICAL CARDIOLOGY, 2001, 24 (10) :663-669
[14]  
Kakadekar AP, 1997, MED PEDIATR ONCOL, V28, P22, DOI 10.1002/(SICI)1096-911X(199701)28:1<22::AID-MPO5>3.0.CO
[15]  
2-V
[16]   Late effects surveillance system for sarcoma patients [J].
Langer, T ;
Stöhr, W ;
Bielack, S ;
Paulussen, M ;
Treuner, J ;
Beck, JD .
PEDIATRIC BLOOD & CANCER, 2004, 42 (04) :373-379
[17]  
Lenk MK, 1998, TURKISH J PEDIATR, V40, P373
[18]   Chronic progressive cardiac dysfunction years after doxorubicin therapy for childhood acute lymphoblastic leukemia [J].
Lipshultz, SE ;
Lipsitz, SR ;
Sallan, SE ;
Dalton, VM ;
Mone, SM ;
Gelber, RD ;
Colan, SD .
JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (12) :2629-2636
[19]   Predictive value of cardiac troponin T in pediatric patients at risk for myocardial injury [J].
Lipshultz, SE ;
Rifai, N ;
Sallan, SE ;
Lipsitz, SR ;
Dalton, V ;
Sacks, DB ;
Ottlinger, ME .
CIRCULATION, 1997, 96 (08) :2641-2648
[20]   LATE CARDIAC EFFECTS OF DOXORUBICIN THERAPY FOR ACUTE LYMPHOBLASTIC-LEUKEMIA IN CHILDHOOD [J].
LIPSHULTZ, SE ;
COLAN, SD ;
GELBER, RD ;
PEREZATAYDE, AR ;
SALLAN, SE ;
SANDERS, SP .
NEW ENGLAND JOURNAL OF MEDICINE, 1991, 324 (12) :808-815